ALIGNMENT HEALTHCARE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.21 USD | +0.97% |
|
+0.19% | -39.49% |
| Apr. 23 | Stifel Adjusts Alignment Healthcare's Price Target to $9 From $11, Maintains Buy Rating | MT |
| Mar. 08 | Transcript : Alignment Healthcare, Inc. - Special Call |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,633 | 2,202 | 1,628 | 993.3 | - | - |
| Enterprise Value (EV) 1 | 2,317 | 1,954 | 1,628 | 993.1 | 1,009 | 984.6 |
| P/E ratio | -12.3 x | -14.2 x | -10.9 x | -8.5 x | -10.2 x | -13.6 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 2.25 x | 1.54 x | 0.89 x | 0.41 x | 0.34 x | 0.29 x |
| EV / Revenue | 1.98 x | 1.36 x | 0.89 x | 0.41 x | 0.35 x | 0.29 x |
| EV / EBITDA | -70 x | -73.1 x | -46.1 x | -343 x | 31.7 x | 20 x |
| EV / FCF | - | -28.2 x | - | -24.9 x | -72.3 x | -60.8 x |
| FCF Yield | - | -3.54% | - | -4.02% | -1.38% | -1.65% |
| Price to Book | - | 9.25 x | - | 8.66 x | 9.57 x | 10.7 x |
| Nbr of stocks (in thousands) | 187,242 | 187,261 | 189,100 | 190,657 | - | - |
| Reference price 2 | 14.06 | 11.76 | 8.610 | 5.210 | 5.210 | 5.210 |
| Announcement Date | 3/3/22 | 2/28/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 959.2 | 1,168 | 1,434 | 1,824 | 2,408 | 2,898 | 3,376 |
| EBITDA 1 | - | -33.12 | -26.72 | -35.32 | -2.896 | 31.81 | 49.24 |
| EBIT 1 | - | -49.15 | -44.2 | -56.99 | -24.65 | 10.32 | 27.53 |
| Operating Margin | - | -4.21% | -3.08% | -3.12% | -1.02% | 0.36% | 0.82% |
| Earnings before Tax (EBT) 1 | - | -195.3 | -149.3 | -148.2 | -125.3 | -110.1 | -107.2 |
| Net income 1 | - | -195.3 | -149.5 | -148 | -114.7 | -97.5 | -76.08 |
| Net margin | - | -16.72% | -10.43% | -8.12% | -4.76% | -3.36% | -2.25% |
| EPS 2 | -36.92 | -1.140 | -0.8300 | -0.7900 | -0.6132 | -0.5098 | -0.3831 |
| Free Cash Flow 1 | - | - | -69.2 | - | -39.9 | -13.95 | -16.2 |
| FCF margin | - | - | -4.83% | - | -1.66% | -0.48% | -0.48% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Announcement Date | 3/3/21 | 3/3/22 | 2/28/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 293.5 | 298.3 | 345.5 | 366.5 | 360.3 | 361.8 | 439.2 | 462.4 | 456.7 | 465.4 | 597.5 | 607.3 | 599.8 | 604 | 713.2 |
| EBITDA 1 | -5.512 | -8.872 | -3.89 | 10.32 | -9.493 | -23.65 | -5.172 | -2.055 | -8.42 | -19.67 | -15.94 | 5.882 | 10.05 | -3.808 | -7.032 |
| EBIT 1 | -9.645 | -13.02 | -36.48 | 6.14 | -14.01 | -28.4 | -10.15 | -7.25 | -13.92 | -25.53 | -20.86 | 0.3367 | 4.402 | -8.532 | -13.13 |
| Operating Margin | -3.29% | -4.37% | -10.56% | 1.68% | -3.89% | -7.85% | -2.31% | -1.57% | -3.05% | -5.49% | -3.49% | 0.06% | 0.73% | -1.41% | -1.84% |
| Earnings before Tax (EBT) 1 | -45.82 | -47.83 | -40.82 | -11.58 | -40.08 | -56.82 | -37.37 | -28.49 | -35.08 | -47.26 | -47.26 | -24.87 | -20.22 | -36.03 | -41.36 |
| Net income 1 | -45.82 | -47.83 | -40.82 | -11.58 | -40.25 | -56.9 | -37.28 | -28.48 | -35.08 | -47.21 | -43.95 | -20.45 | -17.36 | -33.71 | -36.31 |
| Net margin | -15.61% | -16.04% | -11.81% | -3.16% | -11.17% | -15.73% | -8.49% | -6.16% | -7.68% | -10.14% | -7.36% | -3.37% | -2.89% | -5.58% | -5.09% |
| EPS 2 | -0.2600 | -0.2700 | -0.2300 | -0.0600 | -0.2200 | -0.3100 | -0.2000 | -0.1500 | -0.1900 | -0.2500 | -0.2299 | -0.1106 | -0.0928 | -0.1768 | -0.2054 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/4/21 | 3/3/22 | 5/5/22 | 8/4/22 | 11/3/22 | 2/28/23 | 5/4/23 | 8/3/23 | 11/2/23 | 2/27/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | 15.9 | - |
| Net Cash position 1 | - | 316 | 249 | - | 0.26 | - | 8.75 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | 0.499 x | - |
| Free Cash Flow 1 | - | - | -69.2 | - | -39.9 | -14 | -16.2 |
| ROE (net income / shareholders' equity) | - | -116% | -55% | - | -91.8% | -91.5% | -87.8% |
| ROA (Net income/ Total Assets) | - | - | -23.6% | - | -17.7% | -15.1% | - |
| Assets 1 | - | - | 632.4 | - | 648.3 | 645.7 | - |
| Book Value Per Share 2 | - | - | 1.270 | - | 0.6000 | 0.5400 | 0.4900 |
| Cash Flow per Share | - | -0.4600 | -0.2500 | - | - | - | - |
| Capex 1 | - | - | 23.8 | - | 36.3 | 42 | 40 |
| Capex / Sales | - | - | 1.66% | - | 1.51% | 1.45% | 1.18% |
| Announcement Date | 3/3/21 | 3/3/22 | 2/28/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
5.21
USD
Average target price
8
USD
Spread / Average Target
+53.55%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -39.49% | 993M | |
| +13.93% | 125B | |
| +18.37% | 101B | |
| -0.28% | 39.69B | |
| -33.18% | 36.86B | |
| -5.28% | 20.05B | |
| -13.82% | 3.08B | |
| -28.58% | 337M |
- Stock Market
- Equities
- ALHC Stock
- Financials Alignment Healthcare, Inc.
